Titan Medical Announces Closing of US$1.2 Million Registered Direct Offering
H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.
- H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.
- The Common Shares, the Warrants, and the Warrant Shares were offered and sold in the registered direct offering by Titan pursuant to a shelf registration statement on Form F-3 (Registration No.
- Titan Medical Inc. is focused on computer-assisted robotic surgical technologies for application in MIS.
- Titan intends to initially pursue gynecologic surgical indications for use of its single-port robotic surgical system.